« Return to News | R&D Trends | Technology Solutions

etrials Reports $6.1M Loss

Wednesday, November 12, 2008 10:10 AM

Morrisville, N.C.-based eClinical company etrials reported another quarter of loss, with net losses for the third quarter at $6.1 million, compared with $1.3 million for the same period last year and $2.2 million in net losses for the second quarter of 2008.

Net service revenues were $3.7 million for the third quarter of 2008, down from the same period last year ($4.1 million) and the second quarter of 2008 ($4 million).

“etrials’ third quarter performance was somewhat mixed. We made significant progress in reining in expenses, reducing our operating expenses to a $4.9 million run rate,” said etrials’ interim CEO Chuck Piccirillo in company statement. “However, end of quarter backlog was lighter than we would have liked.”

In an investor conference call yesterday, Piccirillo expressed optimism for the fourth quarter of 2008 based on the timing of 17 studies that began or will begin by the end of the year. Piccirillo said etrials has enlisted a financial advisor to help the board explore strategic growth opportunities, including acquiring other companies.

This comment spurred several call-in questions about why, with etrials’ current financial situation, the eClinical company would consider buying other companies rather than selling itself. etrials executives said they will continue to explore “all aspects of opportunity.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.